| ●Editorial | Kageyama S | 390 |
| ●Safety information: reporting, dissemination, and analysis | ||
| Issues on safety information management in Japan | Kobayashi F，Tamura N | 391-7 |
| Handling of safety information during clinical trials with reference to ICH guidance and CIOMS recommendations | E. Stewart Geary | 399-408 |
| （trans. by Nakatsuka M，Boyar E， Pharmacovigilance Working Group） | 409-17 | |
| The PAC (: Professional assessment of causality on ADR reports) Survey Study on DLST in 71,668 cases in Japan | Shimizu N，Koshikawa S， Nomura T，et al. | 419-26 |
| Why are Japanese boys dropping down?: Considerations on the cause of oseltamivir-related abnormal behavior | Saio T | 427-33 |
| ●The 2nd Kyoto University pharmacoepidemiology symposium | ||
| −The role of pharmacoepidemiology in the research and development of new drug− | ||
| Organized by Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University，Supervised by: Kawakami K | 435-537 | |
| ●Proposals and study reports | ||
| Where are we now in the race for innovation?−A proposal of three laws for stronger Japan | Fukushima M | 539-44 |
| Problems regarding the investigational products supply in J-GCP: To promote the global clinical trials | Ono M | 545-54 |
| Coordination report from a post-marketing study carried by a single organization: From the Prevention of Coronary Sclerosis (PCS) study | Uehara Y，Mizuno D， Komatsu M，et al. | 555-70 |
| Basis for the conduct of microdosing clinical trials in Japan: Third report Draft guidance for exploratory investigational new drug clinical trials | Sugiyama Y，Mayahara H， Ikeda T，et al. | 571-94 |
| Proposal of a Draft Human Research Participants Protection Bill 2007 −The most essential legal basis for bioethical issues: Second report− | Mitsuishi T，Nudeshima J， Kurihara C，et al. | 595-611 |
| ●Forum | ||
| How do we translate "should" and "shall" into Japanese? | Uchida E，Kageyama S， Tsubaki H | 613-4 |
| Mitsukoshi Radish Project (MDP), otherwise, Project KFD (Kentucky Fried Data)−Hey! Boys and Girls in Research Lab. How about CRO package service from non-clinical to clinical trial?− | Itoh K | 614-8 |
| ●Instructions for authors [English] | 619-24 | |
| ●Editor's note | Nudeshima J | 625 |
Back to Controller Committee home page
Back to Rinsho Hyoka(Clinical Evaluation)